The European Molecular Biology Organization has named 22 researchers as EMBO Young Investigators, including Rickard Sandberg at the Karolinska Institute in Sweden. Sandberg has been working on methods for single-cell transcriptome sequencing. The EMBO Young Investigators receive €15,000 ($19,400) per year for three years.
Paul Billings has been appointed to Trovagene's scientific advisory board. Billings is currently chief medical officer at Life Technologies and serves on the scientific advisory board of the US Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and the National Academy of Sciences Institute of Medicine's roundtable on genomics. Previously, he served as director and chief scientific officer of El Camino Hospital and senior vice president for corporate development at Laboratory Corporation of America. He holds an MD from Harvard Medical School and a PhD in immunology, also from Harvard.